The need for improved efficacy and fewer side effects also potentiates the development of novel drugs
Ultimately, prospective studies evaluating bone outcomes with different GLP-1 RAs in this population, incorporating standardized DXA assessments and fracture surveillance, are needed to establish evidence-based skeletal health guidelines
We can offer support around diet, exercise, and side effect management that primary care may not always have time to address
Safety Considerations and Who Should Prioritize Hair-Loss Prevention Strategies Individuals with baseline iron-deficiency anemia, zinc malabsorption disorders, or a personal or family history of hair loss conditions should implement preventive micronutrient support before initiating GLP-1 therapy
Illinois Medicaid covers GLP-1s for diabetes
GLP-1 Receptor Agonists in the Treatment of Polycystic Ovary Syndrome